Meta-Analysis
Copyright ©The Author(s) 2022.
World J Gastroenterol. Aug 7, 2022; 28(29): 4007-4018
Published online Aug 7, 2022. doi: 10.3748/wjg.v28.i29.4007
Table 1 Factors influencing local recurrence for polyps ≥ 10 mm at 0–12 mo’ follow-up
Subgroups
LRR % (95%CI)
I2 %
Studies, n
Polyps, n
Resection method, polyps ≥ 10 mm
Hot EMR, no margin ablation15.2 (12.5–18.0)04650
Hot EMR, some margin ablation16.5 (15.2–17.8)063013
Hot EMR, with margin ablation3.3 (2.2–4.5)NA2947
ESD1.7 (0.0–3.4)NA3221
Resection method, polyps ≥ 20 mm
Hot EMR, no margin ablation14.8 (11.0–18.5)NA2334
Hot EMR, some margin ablation16.5 (15.2–17.8)063013
Hot EMR, with margin ablation3.3 (2.2–4.5)NA2947
ESD2.4 (0–5.7)NA283
Polyp size
≥ 10 mm11.0 (7.1–14.8)95.6154904
≥ 20 mm11.2 (6.8–15.6)95.8124431
Expert level
Only expert endoscopists13.3 (11.1–15.6)NA23712
Including non-expert endoscopists11.8 (6.8–16.8)95.89837
Not defined9.2 (1.5–16.9)93.74524
Table 2 Factors influencing incomplete resection
Subgroups
IRR % (95%CI)
I2 %
Studies, n
Polyps, n
Resection method, polyps 10–19 mm
Hot EMR18.5 (8.9–28.1)93.28655
HSP16.2 (10.6–21.7)NA2167
U-EMR25.5 (18.9–32.2)NA2160
Cold EMR114.01 (1.8–26.3)NA3334
Resection method, polyps ≥ 20 mm
ESD12.5 (6.2–18.8)95.091452
Hot EMR 29.3 (19.3–39.2)NA388
Submucosal injection, polyps 10–19 mm
No injection14.4 (5.4–23.3)95.86836
Injection20.0 (11.9–28.0)93.910989
Submucosal injection, polyps ≥ 20 mm
No injection32.4 (0–76.3)96.23124
Injection12.6 (7.7–17.6)94.4131614
Injection solution, polyps ≥ 10 mm
Saline solution15.8 (7.1–24.6)95. 66774
Hyaluronic acid16.3 (8.5–24.1)95.18916
Expert level
Only expert endoscopists7.0 (3.5, 10.4)93. 781451
Including non-expert endoscopists20.3 (13.5–27.1)96.0132092
Method of margin evaluation, polyps 10–19 mm
Margin assessment18.6 (10.9, 26.2)75.15380
Margin biopsy5.7 (1.1, 10.3)95.151150
Method of margin evaluation, polyps ≥ 20 mm
Margin assessment21.8 (9.4–34.2)92.14429
Margin assessment and en bloc resection14.1 (5.7–22.6)96.071106
Margin biopsy0.4 (0–2.5)55.83203